Leucovorin modulation of fluorouracil in advanced colorectal cancer

被引:10
作者
deGramont, A
Louvet, C
Andre, T
Tournigand, C
Raymond, E
Molitor, JL
Krulik, M
机构
来源
REVUE DE MEDECINE INTERNE | 1997年 / 18卷
关键词
leucovorin; 5FU; metastatic colorectal cancer;
D O I
10.1016/S0248-8663(97)83768-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leucovorin modulation of fluorouracil in advanced colorectal cancer. The rational of leucovorin modulation of 5-fluorouracil nad the clinical results in colorectal cancer are reviewed with special emphasis on the monthly schedule of low dose leucovorin and 5FU bolus for 5 consecutive days (NCCTG-Mayo Clinic regimen) and the bimonthly schedule of high-dose leucovorin and 5FU bolus plus continous infusion for two consecutive days (LV5FU2) which is now considered as a new standard.
引用
收藏
页码:S372 / S378
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 1979, HDB REP RES CANC TRE
[2]  
ARANDA E, 1996, 4 S INT TRAT TUM DIG
[3]   A PHASE-II STUDY OF WEEKLY 24-HOUR INFUSION WITH HIGH-DOSE FLUOROURACIL WITH LEUCOVORIN IN COLORECTAL-CARCINOMA [J].
ARDALAN, B ;
CHUA, L ;
TIAN, EM ;
REDDY, R ;
SRIDHAR, K ;
BENEDETTO, P ;
RICHMAN, S ;
LEGASPI, A ;
WALDMAN, S ;
MORRELL, L ;
FEUN, L ;
SAVARAJ, N ;
LIVINGSTONE, A .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :625-630
[4]  
BEERBLOCK K, 1997, CANCER, V79, P1094
[5]  
BORNER MM, 1996, ANN ONCOL S5, V7, P45
[6]   RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER [J].
BUROKER, TR ;
OCONNELL, MJ ;
WIEAND, HS ;
KROOK, JE ;
GERSTNER, JB ;
MAILLIARD, JA ;
SCHAEFER, PL ;
LEVITT, R ;
KARDINAL, CG ;
GESME, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :14-20
[7]   Final results of a randomised trial comparing 'Tomudex'(R) (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer [J].
Cunningham, D ;
Zalcberg, JR ;
Rath, U ;
Oliver, I ;
vanCutsem, E ;
Svensson, C ;
Seitz, JF ;
Harper, P ;
Kerr, D ;
PerezManga, G .
ANNALS OF ONCOLOGY, 1996, 7 (09) :961-965
[8]   Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study [J].
deGramont, A ;
Basset, JF ;
Milan, C ;
Rougier, P ;
Bouche, O ;
Etienne, PL ;
Morvan, F ;
Louvet, C ;
Guillot, C ;
Francois, E ;
Bedenne, L .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :808-815
[9]   EXPECTANCY OR PRIMARY CHEMOTHERAPY IN PATIENTS WITH ADVANCED ASYMPTOMATIC COLORECTAL-CANCER - A RANDOMIZED TRIAL [J].
GLIMELIUS, B ;
PAHLMAN, L ;
GRAF, W ;
ADAMI, HO ;
TVEIT, K ;
HANSEN, J ;
LILJEGREN, G ;
DOMELoF, L ;
LJUNGQVIST, U ;
BERGMAN, L ;
ENANDER, LK ;
UNDERSKOG, I ;
SoDERBERG, M ;
JoNSSON, PE ;
HAFSTRoM, L ;
HEUMAN, R ;
ATHLIN, L ;
SASSNER, P ;
SELLSTRoM, H .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) :904-911
[10]  
GLIMELIUS B, 1994, CANCER, V73, P556, DOI 10.1002/1097-0142(19940201)73:3<556::AID-CNCR2820730310>3.0.CO